(Medical Xpress)—A team of researchers with a startup company called Alkahest will be giving a presentation at this year’s Clinical Trials on Alzheimer’s Disease Conference detailing results of testing blood transfusions on elderly Alzheimer’s patients. They are expected to claim that their testing revealed both null and positive results.
from Dementia Big http://ift.tt/2zi4BHd via alcoholic dementia
http://ift.tt/2h9CrHF
No comments:
Post a Comment